Paste your Google Webmaster Tools verification code here

DNA Sequencing Can Help Spot Glaucoma Defects


Scientists find that spot glaucoma defects can be helped by DNA sequencing. Nevertheless, additional studies on bigger glaucoma quantities of patients are needed to securely establish the connection between genetic defects in glaucoma growth and the mitochondrial genome.


Scientists in the University of Liverpool are treating this ailment in the genetic basis and have begun to sequence the mitochondrial genome in glaucoma patients in expectation of comprehension.

Glaucoma is a condition. It’s an important cause of irreversible blindness on the planet. There are more than 60 million people worldwide suffered from this disorder. Also it’s projected that the amount increases to 79.6 million people by 2020.

Glaucoma will be inherited, and it happens in the life of one. Many scientists consider this state has genetic origins. By this time, many experiments are done as well as the results show that new sequencing strategies may help understand the method by which the state grows.

There are just two primary forms of glaucoma: Open-angle glaucoma and Angle-closure glaucoma. Open-angle glaucoma, also called wide angle glaucoma, is the most frequently encountered form of glaucoma. Studies on primary open-angle glaucoma have proven that mutations in mitochondria could give useful insight into the best way to stop the illness.

By using new gene sequencing techniques called massively parallel sequencing, data has been generated by the Liverpool team in the mitochondrial genome. Mitochondrial gene’s reversal makes it hard for researchers to identify its impact on disease progress. But, by using this new technology, researchers make an effort to supply the medications that are personalized to identify drugs that may target mutated mitochondria.

Read also Signs and Symptoms of Heart Attack

Leave a Reply

Your email address will not be published. Required fields are marked *